StockDrifts LogoStockDrifts

Latest SEC filings

Every 8-K, 10-Q, 10-K, Form 4 and 13D/G as it is filed, each one read and summarised so you can see what actually happened without opening the document.

Filing type

10-K
10-Q
8-K
6-K
Form 4
13D
13G
S-1

Event

Earnings
Guidance
M&A
Executive change
Insider trade
Equity offering
Buybacks & dividends
Index inclusion
Regulatory & legal

Insider action

Insider buy
Insider sell
RXRX
4
Sell

RECURSION PHARMACEUTICALS, INC.

CEO and President Najat Khan sells $78.8K in stock

Najat Khan, CEO and President, sold 22,408 shares of stock worth $78,822.38 under a 10b5-1 plan.

  • CEO and President Najat Khan sold shares.
  • The transaction involved 22,408 shares.
Neutral
Read the filing →
RXRX
4
Sell

RECURSION PHARMACEUTICALS, INC.

Director Blake Borgeson sells $100,200 of stock

Director Blake Borgeson sold 30,000 shares of common stock for a total of $100,200.

  • Blake Borgeson, a Director, sold 30,000 shares.
  • The total value of the transaction was $100,200.00.
Bearish
Read the filing →

Companies on this page